Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer — Stella

Recruiting

Back to Skin Microbiome trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Enrollment target

~326 participants

Started

April 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Sex

Female only

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov